# Microwave Ablation of Primary and Secondary Lung Malignancies

> **NCT04369872** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Calgary** · enrollment: 35 (estimated)

## Conditions studied

- Lung Neoplasms
- Neoplasm Metastasis

## Interventions

- **PROCEDURE:** Microwave ablation

## Key facts

- **NCT ID:** NCT04369872
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2020-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04369872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04369872, "Microwave Ablation of Primary and Secondary Lung Malignancies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04369872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*